+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Cannabis Pharmaceuticals Market by Product Type, Compound Type, Application, Route Of Administration, Distribution Channel, End User - Global Forecast to 2030- Product Image
Cannabis Pharmaceuticals Market by Product Type, Compound Type, Application, Route Of Administration, Distribution Channel, End User - Global Forecast to 2030- Product Image
Sale

Cannabis Pharmaceuticals Market by Product Type, Compound Type, Application, Route Of Administration, Distribution Channel, End User - Global Forecast to 2030

  • PDF Icon

    Report

  • 182 Pages
  • May 2025
  • Region: Global
  • 360iResearch™
  • ID: 6010641
UP TO OFF until Jan 01st 2026
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Cannabis Pharmaceuticals Market grew from USD 1.71 billion in 2024 to USD 2.04 billion in 2025. It is expected to continue growing at a CAGR of 18.80%, reaching USD 4.83 billion by 2030.

Pioneering Therapeutic Frontiers in Cannabis Pharmaceuticals

The cannabis pharmaceuticals sector has emerged from a niche research domain to a cornerstone of modern therapeutic strategies. Advances in extraction technologies and formulation science have unlocked the full potential of cannabinoids, translating decades of anecdotal evidence into rigorously studied treatments. Stakeholders across biopharma, healthcare delivery, and regulatory bodies now converge on common goals: to expand patient access, validate clinical efficacy, and integrate cannabinoid-derived therapies into mainstream protocols.

This report delves into the strategic inflection points shaping this dynamic landscape. It examines the confluence of regulatory reforms, scientific breakthroughs, and market dynamics that collectively define the present moment. As the industry accelerates toward novel drug approvals and standardized manufacturing practices, decision-makers require a holistic understanding of the factors driving demand, investment, and competitive positioning.

Emerging Paradigms Reshaping Cannabis Therapeutics

Recent years have witnessed transformative shifts that redefine how cannabis-based treatments are developed, regulated, and delivered. Regulatory agencies have begun to distinguish between recreational and medicinal applications, creating new pathways for clinical trials and drug approvals. This evolution has prompted major pharmaceutical firms to reevaluate their pipelines, forging collaborations with biotech innovators to harness proprietary cannabinoid derivatives.

Simultaneously, formulation science has progressed beyond raw extracts to sophisticated dosage forms that optimize bioavailability and patient compliance. Microencapsulation techniques, targeted delivery systems, and personalized dosing protocols illustrate the industry’s commitment to therapeutic precision. These advances, coupled with robust real-world evidence initiatives, reinforce confidence among prescribers and payers, laying the groundwork for sustainable commercial expansion.

Evaluating the Ripple Effects of New U.S. Tariff Policies

The implementation of new U.S. tariffs in 2025 introduces a complex layer of trade dynamics affecting both importers and domestic producers of pharmaceutical-grade cannabinoids. Increased duties on precursor materials and finished formulations elevate input costs, prompting manufacturers to reassess supply chain strategies and potentially relocate processing hubs. In reaction, some companies are exploring nearshoring options to mitigate financial exposure and maintain predictable pricing for downstream partners.

On the patient care side, higher costs may translate to adjustments in reimbursement models and insurance coverage policies. Health systems and specialty clinics are evaluating alternative sourcing agreements to ensure continuity of care. At the same time, domestic cultivators and contract manufacturers stand to benefit from a more insulated market environment, as they scale capacity to meet rising demand for U.S.-made therapies. The net effect is a realignment of global trade flows and competitive positioning across the value chain.

Decoding Market Segments Driving Strategic Growth

The market’s product type distribution spans a spectrum of delivery modalities, including both traditional oral solids and innovative topicals. Capsules subdivide into hard shell and soft gel variants, each tailored for specific release profiles. Oils offer broad spectrum, full spectrum, and isolate formats to address varying patient needs. Patches and tinctures provide alternative mechanisms for sustained or rapid onset, while topicals such as creams, lotions, and salves cater to localized treatment in dermatology and pain management.

Compounds under study extend beyond the well-known cannabidiol to include emerging cannabinoids like CBG and CBN, alongside carefully regulated levels of THC. Applications cover a diverse range from dermatological indications to neurological disorders, oncology support, and targeted pain relief. Routes of administration encompass inhalation, oral ingestion, sublingual placement, and topical application, each influencing pharmacokinetic and patient adherence outcomes.

Distribution channels integrate direct-to-patient models with traditional hospital, online, and retail pharmacy networks, enabling flexible access points. End users vary from outpatient clinics and homecare settings to tertiary hospitals and specialized treatment centers, reflecting the broad spectrum of clinical environments that will shape future demand patterns.

Regional Dynamics Shaping Global Cannabis Pharma Uptake

Across the Americas, patient advocacy and insurance frameworks in the United States continue to drive robust demand for cannabinoid therapies, while Canada’s well-established medical program offers a mature blueprint for regulatory harmonization and patient registries. In Europe, Middle East & Africa, the regulatory mosaic presents both challenges and opportunities: the European Medicines Agency pursues unified clinical guidelines even as individual nations differentiate their schedules and access policies, while emerging markets in the Middle East and North Africa test pilot programs that may leapfrog traditional pathways.

In the Asia-Pacific region, a wave of policy reforms is opening doors for therapeutic applications. Australia has already set precedence with structured clinical trial registries, and countries such as Japan and South Korea are cautiously expanding research permissions. At the same time, China’s regulatory posture remains conservative, whereas India’s traditional medicine heritage and growing biotech sector hint at untapped potential. Regional variations in supply chain infrastructure and reimbursement mechanisms further underscore the need for localized go-to-market strategies.

Competitive Landscape Spotlight on Industry Leaders

Leading players in the cannabis pharmaceutical arena showcase a diverse array of strategic approaches. Some focus on in-house proprietary pipelines, investing heavily in synthetic cannabinoid analogs and patented delivery platforms. Others pursue growth through mergers and acquisitions, integrating upstream cultivation assets with downstream formulation expertise to secure end-to-end control of quality and supply.

Collaborations between biotech innovators and established contract development and manufacturing organizations accelerate time to market, leveraging specialized capabilities in GMP production and clinical-scale manufacturing. Strategic alliances with academic centers and research institutes reinforce clinical credibility, while partnerships with digital health platforms enhance patient engagement and remote monitoring. Together, these dynamics shape a competitive landscape defined by agility, scientific rigor, and integrated value chains.

Strategic Imperatives to Capitalize on Market Opportunities

Industry leaders should prioritize innovation in both molecular research and delivery technologies to sustain differentiation. Establishing multidisciplinary teams that bridge pharmacology, formulation science, and digital health will unlock new therapeutic avenues and reinforce patient-centric care models. In parallel, navigating evolving tariff regimes requires diversified sourcing strategies and strategic alliances with domestic manufacturers to reduce exposure to import volatility.

To capture market share, organizations must align product portfolios with emerging reimbursement frameworks, emphasizing real-world evidence generation and health-economic outcomes. Expanding distribution across both traditional pharmacy networks and direct-to-patient channels enhances market reach, while targeted outreach to specialized treatment centers strengthens credibility among key opinion leaders. Embracing data analytics and agile project management practices will further accelerate decision cycles and optimize resource allocation in this rapidly evolving market.

Rigorous Methodology Underpinning Market Findings

This research synthesizes primary interviews with industry executives, clinicians, and regulatory experts alongside a comprehensive review of public filings, peer-reviewed journals, and conference proceedings. Quantitative data undergoes rigorous triangulation, comparing corporate disclosures, proprietary databases, and third-party intelligence to ensure consistency and validity.

Analytical frameworks integrate qualitative insights with market mapping and competitive benchmarking, applying scenario analysis to capture regulatory shifts and trade policy impacts. Findings are validated through stakeholder debriefings, ensuring practical relevance and strategic alignment. This robust methodology underpins the report’s actionable recommendations and enhances confidence in the conclusions drawn.

Synthesizing Insights to Chart the Path Forward

The evolving cannabis pharmaceuticals sector demands agile strategies informed by a deep understanding of regulatory trajectories, supply chain dynamics, and patient needs. By decoding market segments, analyzing regional nuances, and profiling competitive activities, stakeholders can identify high-value opportunities and mitigate emerging risks.

Strategic foresight, coupled with rigorous data validation and cross-functional collaboration, will be essential for navigating the complex interplay of tariffs, clinical innovation, and evolving reimbursement landscapes. The insights presented in this report offer a comprehensive foundation for decision-makers seeking to lead in this transformative therapeutic domain.

Market Segmentation & Coverage

This research report categorizes to forecast the revenues and analyze trends in each of the following sub-segmentations:
  • Product Type
    • Capsule
      • Hard Shell
      • Soft Gel
    • Oil
      • Broad Spectrum
      • Full Spectrum
      • Isolate
    • Patch
    • Tincture
    • Topical
      • Cream
      • Lotion
      • Salve
  • Compound Type
    • Cbd
    • Cbg
    • Cbn
    • Thc
  • Application
    • Dermatology
    • Neurological Disorders
    • Oncology Support
    • Pain Management
  • Route Of Administration
    • Inhalation
    • Oral
    • Sublingual
    • Topical
  • Distribution Channel
    • Direct To Patient Sales
    • Hospital Pharmacies
    • Online Pharmacies
    • Retail Pharmacies
  • End User
    • Clinics
    • Homecare
    • Hospitals
    • Specialized Centers
This research report categorizes to forecast the revenues and analyze trends in each of the following sub-regions:
  • Americas
    • United States
      • California
      • Texas
      • New York
      • Florida
      • Illinois
      • Pennsylvania
      • Ohio
    • Canada
    • Mexico
    • Brazil
    • Argentina
  • Europe, Middle East & Africa
    • United Kingdom
    • Germany
    • France
    • Russia
    • Italy
    • Spain
    • United Arab Emirates
    • Saudi Arabia
    • South Africa
    • Denmark
    • Netherlands
    • Qatar
    • Finland
    • Sweden
    • Nigeria
    • Egypt
    • Turkey
    • Israel
    • Norway
    • Poland
    • Switzerland
  • Asia-Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • Indonesia
    • Thailand
    • Philippines
    • Malaysia
    • Singapore
    • Vietnam
    • Taiwan
This research report categorizes to delves into recent significant developments and analyze trends in each of the following companies:
  • Jazz Pharmaceuticals plc
  • Canopy Growth Corporation
  • Tilray Brands, Inc.
  • Aurora Cannabis Inc.
  • Cronos Group Inc.
  • Curaleaf Holdings, Inc.
  • Trulieve Cannabis Corp.
  • Organigram Holdings Inc.
  • Hexo Corp.
  • MediPharm Labs Corp.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Cannabis Pharmaceuticals Market, by Product Type
8.1. Introduction
8.2. Capsule
8.2.1. Hard Shell
8.2.2. Soft Gel
8.3. Oil
8.3.1. Broad Spectrum
8.3.2. Full Spectrum
8.3.3. Isolate
8.4. Patch
8.5. Tincture
8.6. Topical
8.6.1. Cream
8.6.2. Lotion
8.6.3. Salve
9. Cannabis Pharmaceuticals Market, by Compound Type
9.1. Introduction
9.2. Cbd
9.3. Cbg
9.4. Cbn
9.5. Thc
10. Cannabis Pharmaceuticals Market, by Application
10.1. Introduction
10.2. Dermatology
10.3. Neurological Disorders
10.4. Oncology Support
10.5. Pain Management
11. Cannabis Pharmaceuticals Market, by Route Of Administration
11.1. Introduction
11.2. Inhalation
11.3. Oral
11.4. Sublingual
11.5. Topical
12. Cannabis Pharmaceuticals Market, by Distribution Channel
12.1. Introduction
12.2. Direct To Patient Sales
12.3. Hospital Pharmacies
12.4. Online Pharmacies
12.5. Retail Pharmacies
13. Cannabis Pharmaceuticals Market, by End User
13.1. Introduction
13.2. Clinics
13.3. Homecare
13.4. Hospitals
13.5. Specialized Centers
14. Americas Cannabis Pharmaceuticals Market
14.1. Introduction
14.2. United States
14.3. Canada
14.4. Mexico
14.5. Brazil
14.6. Argentina
15. Europe, Middle East & Africa Cannabis Pharmaceuticals Market
15.1. Introduction
15.2. United Kingdom
15.3. Germany
15.4. France
15.5. Russia
15.6. Italy
15.7. Spain
15.8. United Arab Emirates
15.9. Saudi Arabia
15.10. South Africa
15.11. Denmark
15.12. Netherlands
15.13. Qatar
15.14. Finland
15.15. Sweden
15.16. Nigeria
15.17. Egypt
15.18. Turkey
15.19. Israel
15.20. Norway
15.21. Poland
15.22. Switzerland
16. Asia-Pacific Cannabis Pharmaceuticals Market
16.1. Introduction
16.2. China
16.3. India
16.4. Japan
16.5. Australia
16.6. South Korea
16.7. Indonesia
16.8. Thailand
16.9. Philippines
16.10. Malaysia
16.11. Singapore
16.12. Vietnam
16.13. Taiwan
17. Competitive Landscape
17.1. Market Share Analysis, 2024
17.2. FPNV Positioning Matrix, 2024
17.3. Competitive Analysis
17.3.1. Jazz Pharmaceuticals plc
17.3.2. Canopy Growth Corporation
17.3.3. Tilray Brands, Inc.
17.3.4. Aurora Cannabis Inc.
17.3.5. Cronos Group Inc.
17.3.6. Curaleaf Holdings, Inc.
17.3.7. Trulieve Cannabis Corp.
17.3.8. Organigram Holdings Inc.
17.3.9. Hexo Corp.
17.3.10. MediPharm Labs Corp.
18. ResearchAI
19. ResearchStatistics
20. ResearchContacts
21. ResearchArticles
22. Appendix
List of Figures
FIGURE 1. CANNABIS PHARMACEUTICALS MARKET MULTI-CURRENCY
FIGURE 2. CANNABIS PHARMACEUTICALS MARKET MULTI-LANGUAGE
FIGURE 3. CANNABIS PHARMACEUTICALS MARKET RESEARCH PROCESS
FIGURE 4. GLOBAL CANNABIS PHARMACEUTICALS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 5. GLOBAL CANNABIS PHARMACEUTICALS MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 6. GLOBAL CANNABIS PHARMACEUTICALS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL CANNABIS PHARMACEUTICALS MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2030 (%)
FIGURE 8. GLOBAL CANNABIS PHARMACEUTICALS MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL CANNABIS PHARMACEUTICALS MARKET SIZE, BY COMPOUND TYPE, 2024 VS 2030 (%)
FIGURE 10. GLOBAL CANNABIS PHARMACEUTICALS MARKET SIZE, BY COMPOUND TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL CANNABIS PHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2024 VS 2030 (%)
FIGURE 12. GLOBAL CANNABIS PHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL CANNABIS PHARMACEUTICALS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024 VS 2030 (%)
FIGURE 14. GLOBAL CANNABIS PHARMACEUTICALS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. GLOBAL CANNABIS PHARMACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2030 (%)
FIGURE 16. GLOBAL CANNABIS PHARMACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. GLOBAL CANNABIS PHARMACEUTICALS MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 18. GLOBAL CANNABIS PHARMACEUTICALS MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. AMERICAS CANNABIS PHARMACEUTICALS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 20. AMERICAS CANNABIS PHARMACEUTICALS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. UNITED STATES CANNABIS PHARMACEUTICALS MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 22. UNITED STATES CANNABIS PHARMACEUTICALS MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. EUROPE, MIDDLE EAST & AFRICA CANNABIS PHARMACEUTICALS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 24. EUROPE, MIDDLE EAST & AFRICA CANNABIS PHARMACEUTICALS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 25. ASIA-PACIFIC CANNABIS PHARMACEUTICALS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 26. ASIA-PACIFIC CANNABIS PHARMACEUTICALS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 27. CANNABIS PHARMACEUTICALS MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 28. CANNABIS PHARMACEUTICALS MARKET, FPNV POSITIONING MATRIX, 2024
List of Tables
TABLE 1. CANNABIS PHARMACEUTICALS MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL CANNABIS PHARMACEUTICALS MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL CANNABIS PHARMACEUTICALS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. GLOBAL CANNABIS PHARMACEUTICALS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 6. GLOBAL CANNABIS PHARMACEUTICALS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 7. GLOBAL CANNABIS PHARMACEUTICALS MARKET SIZE, BY CAPSULE, BY REGION, 2018-2030 (USD MILLION)
TABLE 8. GLOBAL CANNABIS PHARMACEUTICALS MARKET SIZE, BY HARD SHELL, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. GLOBAL CANNABIS PHARMACEUTICALS MARKET SIZE, BY SOFT GEL, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. GLOBAL CANNABIS PHARMACEUTICALS MARKET SIZE, BY CAPSULE, 2018-2030 (USD MILLION)
TABLE 11. GLOBAL CANNABIS PHARMACEUTICALS MARKET SIZE, BY OIL, BY REGION, 2018-2030 (USD MILLION)
TABLE 12. GLOBAL CANNABIS PHARMACEUTICALS MARKET SIZE, BY BROAD SPECTRUM, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. GLOBAL CANNABIS PHARMACEUTICALS MARKET SIZE, BY FULL SPECTRUM, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. GLOBAL CANNABIS PHARMACEUTICALS MARKET SIZE, BY ISOLATE, BY REGION, 2018-2030 (USD MILLION)
TABLE 15. GLOBAL CANNABIS PHARMACEUTICALS MARKET SIZE, BY OIL, 2018-2030 (USD MILLION)
TABLE 16. GLOBAL CANNABIS PHARMACEUTICALS MARKET SIZE, BY PATCH, BY REGION, 2018-2030 (USD MILLION)
TABLE 17. GLOBAL CANNABIS PHARMACEUTICALS MARKET SIZE, BY TINCTURE, BY REGION, 2018-2030 (USD MILLION)
TABLE 18. GLOBAL CANNABIS PHARMACEUTICALS MARKET SIZE, BY TOPICAL, BY REGION, 2018-2030 (USD MILLION)
TABLE 19. GLOBAL CANNABIS PHARMACEUTICALS MARKET SIZE, BY CREAM, BY REGION, 2018-2030 (USD MILLION)
TABLE 20. GLOBAL CANNABIS PHARMACEUTICALS MARKET SIZE, BY LOTION, BY REGION, 2018-2030 (USD MILLION)
TABLE 21. GLOBAL CANNABIS PHARMACEUTICALS MARKET SIZE, BY SALVE, BY REGION, 2018-2030 (USD MILLION)
TABLE 22. GLOBAL CANNABIS PHARMACEUTICALS MARKET SIZE, BY TOPICAL, 2018-2030 (USD MILLION)
TABLE 23. GLOBAL CANNABIS PHARMACEUTICALS MARKET SIZE, BY COMPOUND TYPE, 2018-2030 (USD MILLION)
TABLE 24. GLOBAL CANNABIS PHARMACEUTICALS MARKET SIZE, BY CBD, BY REGION, 2018-2030 (USD MILLION)
TABLE 25. GLOBAL CANNABIS PHARMACEUTICALS MARKET SIZE, BY CBG, BY REGION, 2018-2030 (USD MILLION)
TABLE 26. GLOBAL CANNABIS PHARMACEUTICALS MARKET SIZE, BY CBN, BY REGION, 2018-2030 (USD MILLION)
TABLE 27. GLOBAL CANNABIS PHARMACEUTICALS MARKET SIZE, BY THC, BY REGION, 2018-2030 (USD MILLION)
TABLE 28. GLOBAL CANNABIS PHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 29. GLOBAL CANNABIS PHARMACEUTICALS MARKET SIZE, BY DERMATOLOGY, BY REGION, 2018-2030 (USD MILLION)
TABLE 30. GLOBAL CANNABIS PHARMACEUTICALS MARKET SIZE, BY NEUROLOGICAL DISORDERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 31. GLOBAL CANNABIS PHARMACEUTICALS MARKET SIZE, BY ONCOLOGY SUPPORT, BY REGION, 2018-2030 (USD MILLION)
TABLE 32. GLOBAL CANNABIS PHARMACEUTICALS MARKET SIZE, BY PAIN MANAGEMENT, BY REGION, 2018-2030 (USD MILLION)
TABLE 33. GLOBAL CANNABIS PHARMACEUTICALS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 34. GLOBAL CANNABIS PHARMACEUTICALS MARKET SIZE, BY INHALATION, BY REGION, 2018-2030 (USD MILLION)
TABLE 35. GLOBAL CANNABIS PHARMACEUTICALS MARKET SIZE, BY ORAL, BY REGION, 2018-2030 (USD MILLION)
TABLE 36. GLOBAL CANNABIS PHARMACEUTICALS MARKET SIZE, BY SUBLINGUAL, BY REGION, 2018-2030 (USD MILLION)
TABLE 37. GLOBAL CANNABIS PHARMACEUTICALS MARKET SIZE, BY TOPICAL, BY REGION, 2018-2030 (USD MILLION)
TABLE 38. GLOBAL CANNABIS PHARMACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 39. GLOBAL CANNABIS PHARMACEUTICALS MARKET SIZE, BY DIRECT TO PATIENT SALES, BY REGION, 2018-2030 (USD MILLION)
TABLE 40. GLOBAL CANNABIS PHARMACEUTICALS MARKET SIZE, BY HOSPITAL PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 41. GLOBAL CANNABIS PHARMACEUTICALS MARKET SIZE, BY ONLINE PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 42. GLOBAL CANNABIS PHARMACEUTICALS MARKET SIZE, BY RETAIL PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 43. GLOBAL CANNABIS PHARMACEUTICALS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 44. GLOBAL CANNABIS PHARMACEUTICALS MARKET SIZE, BY CLINICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 45. GLOBAL CANNABIS PHARMACEUTICALS MARKET SIZE, BY HOMECARE, BY REGION, 2018-2030 (USD MILLION)
TABLE 46. GLOBAL CANNABIS PHARMACEUTICALS MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 47. GLOBAL CANNABIS PHARMACEUTICALS MARKET SIZE, BY SPECIALIZED CENTERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 48. AMERICAS CANNABIS PHARMACEUTICALS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 49. AMERICAS CANNABIS PHARMACEUTICALS MARKET SIZE, BY CAPSULE, 2018-2030 (USD MILLION)
TABLE 50. AMERICAS CANNABIS PHARMACEUTICALS MARKET SIZE, BY OIL, 2018-2030 (USD MILLION)
TABLE 51. AMERICAS CANNABIS PHARMACEUTICALS MARKET SIZE, BY TOPICAL, 2018-2030 (USD MILLION)
TABLE 52. AMERICAS CANNABIS PHARMACEUTICALS MARKET SIZE, BY COMPOUND TYPE, 2018-2030 (USD MILLION)
TABLE 53. AMERICAS CANNABIS PHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 54. AMERICAS CANNABIS PHARMACEUTICALS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 55. AMERICAS CANNABIS PHARMACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 56. AMERICAS CANNABIS PHARMACEUTICALS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 57. AMERICAS CANNABIS PHARMACEUTICALS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 58. UNITED STATES CANNABIS PHARMACEUTICALS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 59. UNITED STATES CANNABIS PHARMACEUTICALS MARKET SIZE, BY CAPSULE, 2018-2030 (USD MILLION)
TABLE 60. UNITED STATES CANNABIS PHARMACEUTICALS MARKET SIZE, BY OIL, 2018-2030 (USD MILLION)
TABLE 61. UNITED STATES CANNABIS PHARMACEUTICALS MARKET SIZE, BY TOPICAL, 2018-2030 (USD MILLION)
TABLE 62. UNITED STATES CANNABIS PHARMACEUTICALS MARKET SIZE, BY COMPOUND TYPE, 2018-2030 (USD MILLION)
TABLE 63. UNITED STATES CANNABIS PHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 64. UNITED STATES CANNABIS PHARMACEUTICALS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 65. UNITED STATES CANNABIS PHARMACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 66. UNITED STATES CANNABIS PHARMACEUTICALS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 67. UNITED STATES CANNABIS PHARMACEUTICALS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 68. CANADA CANNABIS PHARMACEUTICALS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 69. CANADA CANNABIS PHARMACEUTICALS MARKET SIZE, BY CAPSULE, 2018-2030 (USD MILLION)
TABLE 70. CANADA CANNABIS PHARMACEUTICALS MARKET SIZE, BY OIL, 2018-2030 (USD MILLION)
TABLE 71. CANADA CANNABIS PHARMACEUTICALS MARKET SIZE, BY TOPICAL, 2018-2030 (USD MILLION)
TABLE 72. CANADA CANNABIS PHARMACEUTICALS MARKET SIZE, BY COMPOUND TYPE, 2018-2030 (USD MILLION)
TABLE 73. CANADA CANNABIS PHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 74. CANADA CANNABIS PHARMACEUTICALS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 75. CANADA CANNABIS PHARMACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 76. CANADA CANNABIS PHARMACEUTICALS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 77. MEXICO CANNABIS PHARMACEUTICALS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 78. MEXICO CANNABIS PHARMACEUTICALS MARKET SIZE, BY CAPSULE, 2018-2030 (USD MILLION)
TABLE 79. MEXICO CANNABIS PHARMACEUTICALS MARKET SIZE, BY OIL, 2018-2030 (USD MILLION)
TABLE 80. MEXICO CANNABIS PHARMACEUTICALS MARKET SIZE, BY TOPICAL, 2018-2030 (USD MILLION)
TABLE 81. MEXICO CANNABIS PHARMACEUTICALS MARKET SIZE, BY COMPOUND TYPE, 2018-2030 (USD MILLION)
TABLE 82. MEXICO CANNABIS PHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 83. MEXICO CANNABIS PHARMACEUTICALS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 84. MEXICO CANNABIS PHARMACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 85. MEXICO CANNABIS PHARMACEUTICALS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 86. BRAZIL CANNABIS PHARMACEUTICALS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 87. BRAZIL CANNABIS PHARMACEUTICALS MARKET SIZE, BY CAPSULE, 2018-2030 (USD MILLION)
TABLE 88. BRAZIL CANNABIS PHARMACEUTICALS MARKET SIZE, BY OIL, 2018-2030 (USD MILLION)
TABLE 89. BRAZIL CANNABIS PHARMACEUTICALS MARKET SIZE, BY TOPICAL, 2018-2030 (USD MILLION)
TABLE 90. BRAZIL CANNABIS PHARMACEUTICALS MARKET SIZE, BY COMPOUND TYPE, 2018-2030 (USD MILLION)
TABLE 91. BRAZIL CANNABIS PHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 92. BRAZIL CANNABIS PHARMACEUTICALS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 93. BRAZIL CANNABIS PHARMACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 94. BRAZIL CANNABIS PHARMACEUTICALS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 95. ARGENTINA CANNABIS PHARMACEUTICALS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 96. ARGENTINA CANNABIS PHARMACEUTICALS MARKET SIZE, BY CAPSULE, 2018-2030 (USD MILLION)
TABLE 97. ARGENTINA CANNABIS PHARMACEUTICALS MARKET SIZE, BY OIL, 2018-2030 (USD MILLION)
TABLE 98. ARGENTINA CANNABIS PHARMACEUTICALS MARKET SIZE, BY TOPICAL, 2018-2030 (USD MILLION)
TABLE 99. ARGENTINA CANNABIS PHARMACEUTICALS MARKET SIZE, BY COMPOUND TYPE, 2018-2030 (USD MILLION)
TABLE 100. ARGENTINA CANNABIS PHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 101. ARGENTINA CANNABIS PHARMACEUTICALS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 102. ARGENTINA CANNABIS PHARMACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 103. ARGENTINA CANNABIS PHARMACEUTICALS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 104. EUROPE, MIDDLE EAST & AFRICA CANNABIS PHARMACEUTICALS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 105. EUROPE, MIDDLE EAST & AFRICA CANNABIS PHARMACEUTICALS MARKET SIZE, BY CAPSULE, 2018-2030 (USD MILLION)
TABLE 106. EUROPE, MIDDLE EAST & AFRICA CANNABIS PHARMACEUTICALS MARKET SIZE, BY OIL, 2018-2030 (USD MILLION)
TABLE 107. EUROPE, MIDDLE EAST & AFRICA CANNABIS PHARMACEUTICALS MARKET SIZE, BY TOPICAL, 2018-2030 (USD MILLION)
TABLE 108. EUROPE, MIDDLE EAST & AFRICA CANNABIS PHARMACEUTICALS MARKET SIZE, BY COMPOUND TYPE, 2018-2030 (USD MILLION)
TABLE 109. EUROPE, MIDDLE EAST & AFRICA CANNABIS PHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 110. EUROPE, MIDDLE EAST & AFRICA CANNABIS PHARMACEUTICALS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 111. EUROPE, MIDDLE EAST & AFRICA CANNABIS PHARMACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 112. EUROPE, MIDDLE EAST & AFRICA CANNABIS PHARMACEUTICALS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 113. EUROPE, MIDDLE EAST & AFRICA CANNABIS PHARMACEUTICALS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 114. UNITED KINGDOM CANNABIS PHARMACEUTICALS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 115. UNITED KINGDOM CANNABIS PHARMACEUTICALS MARKET SIZE, BY CAPSULE, 2018-2030 (USD MILLION)
TABLE 116. UNITED KINGDOM CANNABIS PHARMACEUTICALS MARKET SIZE, BY OIL, 2018-2030 (USD MILLION)
TABLE 117. UNITED KINGDOM CANNABIS PHARMACEUTICALS MARKET SIZE, BY TOPICAL, 2018-2030 (USD MILLION)
TABLE 118. UNITED KINGDOM CANNABIS PHARMACEUTICALS MARKET SIZE, BY COMPOUND TYPE, 2018-2030 (USD MILLION)
TABLE 119. UNITED KINGDOM CANNABIS PHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 120. UNITED KINGDOM CANNABIS PHARMACEUTICALS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 121. UNITED KINGDOM CANNABIS PHARMACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 122. UNITED KINGDOM CANNABIS PHARMACEUTICALS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 123. GERMANY CANNABIS PHARMACEUTICALS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 124. GERMANY CANNABIS PHARMACEUTICALS MARKET SIZE, BY CAPSULE, 2018-2030 (USD MILLION)
TABLE 125. GERMANY CANNABIS PHARMACEUTICALS MARKET SIZE, BY OIL, 2018-2030 (USD MILLION)
TABLE 126. GERMANY CANNABIS PHARMACEUTICALS MARKET SIZE, BY TOPICAL, 2018-2030 (USD MILLION)
TABLE 127. GERMANY CANNABIS PHARMACEUTICALS MARKET SIZE, BY COMPOUND TYPE, 2018-2030 (USD MILLION)
TABLE 128. GERMANY CANNABIS PHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 129. GERMANY CANNABIS PHARMACEUTICALS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 130. GERMANY CANNABIS PHARMACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 131. GERMANY CANNABIS PHARMACEUTICALS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 132. FRANCE CANNABIS PHARMACEUTICALS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 133. FRANCE CANNABIS PHARMACEUTICALS MARKET SIZE, BY CAPSULE, 2018-2030 (USD MILLION)
TABLE 134. FRANCE CANNABIS PHARMACEUTICALS MARKET SIZE, BY OIL, 2018-2030 (USD MILLION)
TABLE 135. FRANCE CANNABIS PHARMACEUTICALS MARKET SIZE, BY TOPICAL, 2018-2030 (USD MILLION)
TABLE 136. FRANCE CANNABIS PHARMACEUTICALS MARKET SIZE, BY COMPOUND TYPE, 2018-2030 (USD MILLION)
TABLE 137. FRANCE CANNABIS PHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 138. FRANCE CANNABIS PHARMACEUTICALS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 139. FRANCE CANNABIS PHARMACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 140. FRANCE CANNABIS PHARMACEUTICALS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 141. RUSSIA CANNABIS PHARMACEUTICALS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 142. RUSSIA CANNABIS PHARMACEUTICALS MARKET SIZE, BY CAPSULE, 2018-2030 (USD MILLION)
TABLE 143. RUSSIA CANNABIS PHARMACEUTICALS MARKET SIZE, BY OIL, 2018-2030 (USD MILLION)
TABLE 144. RUSSIA CANNABIS PHARMACEUTICALS MARKET SIZE, BY TOPICAL, 2018-2030 (USD MILLION)
TABLE 145. RUSSIA CANNABIS PHARMACEUTICALS MARKET SIZE, BY COMPOUND TYPE, 2018-2030 (USD MILLION)
TABLE 146. RUSSIA CANNABIS PHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 147. RUSSIA CANNABIS PHARMACEUTICALS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 148. RUSSIA CANNABIS PHARMACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 149. RUSSIA CANNABIS PHARMACEUTICALS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 150. ITALY CANNABIS PHARMACEUTICALS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 151. ITALY CANNABIS PHARMACEUTICALS MARKET SIZE, BY CAPSULE, 2018-2030 (USD MILLION)
TABLE 152. ITALY CANNABIS PHARMACEUTICALS MARKET SIZE, BY OIL, 2018-2030 (USD MILLION)
TABLE 153. ITALY CANNABIS PHARMACEUTICALS MARKET SIZE, BY TOPICAL, 2018-2030 (USD MILLION)
TABLE 154. ITALY CANNABIS PHARMACEUTICALS MARKET SIZE, BY COMPOUND TYPE, 2018-2030 (USD MILLION)
TABLE 155. ITALY CANNABIS PHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 156. ITALY CANNABIS PHARMACEUTICALS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 157. ITALY CANNABIS PHARMACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 158. ITALY CANNABIS PHARMACEUTICALS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 159. SPAIN CANNABIS PHARMACEUTICALS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 160. SPAIN CANNABIS PHARMACEUTICALS MARKET SIZE, BY CAPSULE, 2018-2030 (USD MILLION)
TABLE 161. SPAIN CANNABIS PHARMACEUTICALS MARKET SIZE, BY OIL, 2018-2030 (USD MILLION)
TABLE 162. SPAIN CANNABIS PHARMACEUTICALS MARKET SIZE, BY TOPICAL, 2018-2030 (USD MILLION)
TABLE 163. SPAIN CANNABIS PHARMACEUTICALS MARKET SIZE, BY COMPOUND TYPE, 2018-2030 (USD MILLION)
TABLE 164. SPAIN CANNABIS PHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 165. SPAIN CANNABIS PHARMACEUTICALS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 166. SPAIN CANNABIS PHARMACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 167. SPAIN CANNABIS PHARMACEUTICALS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 168. UNITED ARAB EMIRATES CANNABIS PHARMACEUTICALS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 169. UNITED ARAB EMIRATES CANNABIS PHARMACEUTICALS MARKET SIZE, BY CAPSULE, 2018-2030 (USD MILLION)
TABLE 170. UNITED ARAB EMIRATES CANNABIS PHARMACEUTICALS MARKET SIZE, BY OIL, 2018-2030 (USD MILLION)
TABLE 171. UNITED ARAB EMIRATES CANNABIS PHARMACEUTICALS MARKET SIZE, BY TOPICAL, 2018-2030 (USD MILLION)
TABLE 172. UNITED ARAB EMIRATES CANNABIS PHARMACEUTICALS MARKET SIZE, BY COMPOUND TYPE, 2018-2030 (USD MILLION)
TABLE 173. UNITED ARAB EMIRATES CANNABIS PHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 174. UNITED ARAB EMIRATES CANNABIS PHARMACEUTICALS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 175. UNITED ARAB EMIRATES CANNABIS PHARMACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 176. UNITED ARAB EMIRATES CANNABIS PHARMACEUTICALS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 177. SAUDI ARABIA CANNABIS PHARMACEUTICALS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 178. SAUDI ARABIA CANNABIS PHARMACEUTICALS MARKET SIZE, BY CAPSULE, 2018-2030 (USD MILLION)
TABLE 179. SAUDI ARABIA CANNABIS PHARMACEUTICALS MARKET SIZE, BY OIL, 2018-2030 (USD MILLION)
TABLE 180. SAUDI ARABIA CANNABIS PHARMACEUTICALS MARKET SIZE, BY TOPICAL, 2018-2030 (USD MILLION)
TABLE 181. SAUDI ARABIA CANNABIS PHARMACEUTICALS MARKET SIZE, BY COMPOUND TYPE, 2018-2030 (USD MILLION)
TABLE 182. SAUDI ARABIA CANNABIS PHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 183. SAUDI ARABIA CANNABIS PHARMACEUTICALS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 184. SAUDI ARABIA CANNABIS PHARMACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 185. SAUDI ARABIA CANNABIS PHARMACEUTICALS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 186. SOUTH AFRICA CANNABIS PHARMACEUTICALS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 187. SOUTH AFRICA CANNABIS PHARMACEUTICALS MARKET SIZE, BY CAPSULE, 2018-2030 (USD MILLION)
TABLE 188. SOUTH AFRICA CANNABIS PHARMACEUTICALS MARKET SIZE, BY OIL, 2018-2030 (USD MILLION)
TABLE 189. SOUTH AFRICA CANNABIS PHARMACEUTICALS MARKET SIZE, BY TOPICAL, 2018-2030 (USD MILLION)
TABLE 190. SOUTH AFRICA CANNABIS PHARMACEUTICALS MARKET SIZE, BY COMPOUND TYPE, 2018-2030 (USD MILLION)
TABLE 191. SOUTH AFRICA CANNABIS PHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 192. SOUTH AFRICA CANNABIS PHARMACEUTICALS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 193. SOUTH AFRICA CANNABIS PHARMACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 194. SOUTH AFRICA CANNABIS PHARMACEUTICALS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 195. DENMARK CANNABIS PHARMACEUTICALS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 196. DENMARK CANNABIS PHARMACEUTICALS MARKET SIZE, BY CAPSULE, 2018-2030 (USD MILLION)
TABLE 197. DENMARK CANNABIS PHARMACEUTICALS MARKET SIZE, BY OIL, 2018-2030 (USD MILLION)
TABLE 198. DENMARK CANNABIS PHARMACEUTICALS MARKET SIZE, BY TOPICAL, 2018-2030 (USD MILLION)
TABLE 199. DENMARK CANNABIS PHARMACEUTICALS MARKET SIZE, BY COMPOUND TYPE, 2018-2030 (USD MILLION)
TABLE 200. DENMARK CANNABIS PHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 201. DENMARK CANNABIS PHARMACEUTICALS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 202. DENMARK CANNABIS PHARMACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 203. DENMARK CANNABIS PHARMACEUTICALS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 204. NETHERLANDS CANNABIS PHARMACEUTICALS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 205. NETHERLANDS CANNABIS PHARMACEUTICALS MARKET SIZE, BY CAPSULE, 2018-2030 (USD MILLION)
TABLE 206. NETHERLANDS CANNABIS PHARMACEUTICALS MARKET SIZE, BY OIL, 2018-2030 (USD MILLION)
TABLE 207. NETHERLANDS CANNABIS PHARMACEUTICALS MARKET SIZE, BY TOPICAL, 2018-2030 (USD MILLION)
TABLE 208. NETHERLANDS CANNABIS PHARMACEUTICALS MARKET SIZE, BY COMPOUND TYPE, 2018-2030 (USD MILLION)
TABLE 209. NETHERLANDS CANNABIS PHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 210. NETHERLANDS CANNABIS PHARMACEUTICALS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 211. NETHERLANDS CANNABIS PHARMACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 212. NETHERLANDS CANNABIS PHARMACEUTICALS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 213. QATAR CANNABIS PHARMACEUTICALS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 214. QATAR CANNABIS PHARMACEUTICALS MARKET SIZE, BY CAPSULE, 2018-2030 (USD MILLION)
TABLE 215. QATAR CANNABIS PHARMACEUTICALS MARKET SIZE, BY OIL, 2018-2030 (USD MILLION)
TABLE 216. QATAR CANNABIS PHARMACEUTICALS MARKET SIZE, BY TOPICAL, 2018-2030 (USD MILLION)
TABLE 217. QATAR CANNABIS PHARMACEUTICALS MARKET SIZE, BY COMPOUND TYPE, 2018-2030 (USD MILLION)
TABLE 218. QATAR CANNABIS PHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 219. QATAR CANNABIS PHARMACEUTICALS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 220. QATAR CANNABIS PHARMACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 221. QATAR CANNABIS PHARMACEUTICALS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 222. FINLAND CANNABIS PHARMACEUTICALS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 223. FINLAND CANNABIS PHARMACEUTICALS MARKET SIZE, BY CAPSULE, 2018-2030 (USD MILLION)
TABLE 224. FINLAND CANNABIS PHARMACEUTICALS MARKET SIZE, BY OIL, 2018-2030 (USD MILLION)
TABLE 225. FINLAND CANNABIS PHARMACEUTICALS MARKET SIZE, BY TOPICAL, 2018-2030 (USD MILLION)
TABLE 226. FINLAND CANNABIS PHARMACEUTICALS MARKET SIZE, BY COMPOUND TYPE, 2018-2030 (USD MILLION)
TABLE 227. FINLAND CANNABIS PHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 228. FINLAND CANNABIS PHARMACEUTICALS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 229. FINLAND CANNABIS PHARMACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 230. FINLAND CANNABIS PHARMACEUTICALS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 231. SWEDEN CANNABIS PHARMACEUTICALS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 232. SWEDEN CANNABIS PHARMACEUTICALS MARKET SIZE, BY CAPSULE, 2018-2030 (USD MILLION)
TABLE 233. SWEDEN CANNABIS PHARMACEUTICALS MARKET SIZE, BY OIL, 2018-2030 (USD MILLION)
TABLE 234. SWEDEN CANNABIS PHARMACEUTICALS MARKET SIZE, BY TOPICAL, 2018-2030 (USD MILLION)
TABLE 235. SWEDEN CANNABIS PHARMACEUTICALS MARKET SIZE, BY COMPOUND TYPE, 2018-2030 (USD MILLION)
TABLE 236. SWEDEN CANNABIS PHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 237. SWEDEN CANNABIS PHARMACEUTICALS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 238. SWEDEN CANNABIS PHARMACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 239. SWEDEN CANNABIS PHARMACEUTICALS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 240. NIGERIA CANNABIS PHARMACEUTICALS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 241. NIGERIA CANNABIS PHARMACEUTICALS MARKET SIZE, BY CAPSULE, 2018-2030 (USD MILLION)
TABLE 242. NIGERIA CANNABIS PHARMACEUTICALS MARKET SIZE, BY OIL, 2018-2030 (USD MILLION)
TABLE 243. NIGERIA CANNABIS PHARMACEUTICALS MARKET SIZE, BY TOPICAL, 2018-2030 (USD MILLION)
TABLE 244. NIGERIA CANNABIS PHARMACEUTICALS MARKET SIZE, BY COMPOUND TYPE, 2018-2030 (USD MILLION)
TABLE 245. NIGERIA CANNABIS PHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 246. NIGERIA CANNABIS PHARMACEUTICALS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 247. NIGERIA CANNABIS PHARMACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 248. NIGERIA CANNABIS PHARMACEUTICALS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 249. EGYPT CANNABIS PHARMACEUTICALS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 250. EGYPT CANNABIS PHARMACEUTICALS MARKET SIZE, BY CAPSULE, 2018-2030 (USD MILLION)
TABLE 251. EGYPT CANNABIS PHARMACEUTICALS MARKET SIZE, BY OIL, 2018-2030 (USD MILLION)
TABLE 252. EGYPT CANNABIS PHARMACEUTICALS MARKET SIZE, BY TOPICAL, 2018-2030 (USD MILLION)
TABLE 253. EGYPT CANNABIS PHARMACEUTICALS MARKET SIZE, BY COMPOUND TYPE, 2018-2030 (USD MILLION)
TABLE 254. EGYPT CANNABIS PHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 255. EGYPT CANNABIS PHARMACEUTICALS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 256. EGYPT CANNABIS PHARMACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 257. EGYPT CANNABIS PHARMACEUTICALS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 258. TURKEY CANNABIS PHARMACEUTICALS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 259. TURKEY CANNABIS PHARMACEUTICALS MARKET SIZE, BY CAPSULE, 2018-2030 (USD MILLION)
TABLE 260. TURKEY CANNABIS PHARMACEUTICALS MARKET SIZE, BY OIL, 2018-2030 (USD MILLION)
TABLE 261. TURKEY CANNABIS PHARMACEUTICALS MARKET SIZE, BY TOPICAL, 2018-2030 (USD MILLION)
TABLE 262. TURKEY CANNABIS PHARMACEUTICALS MARKET SIZE, BY COMPOUND TYPE, 2018-2030 (USD MILLION)
TABLE 263. TURKEY CANNABIS PHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 264. TURKEY CANNABIS PHARMACEUTICALS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 265. TURKEY CANNABIS PHARMACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 266. TURKEY CANNABIS PHARMACEUTICALS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 267. ISRAEL CANNABIS PHARMACEUTICALS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 268. ISRAEL CANNABIS PHARMACEUTICALS MARKET SIZE, BY CAPSULE, 2018-2030 (USD MILLION)
TABLE 269. ISRAEL CANNABIS PHARMACEUTICALS MARKET SIZE, BY OIL, 2018-2030 (USD MILLION)
TABLE 270. ISRAEL CANNABIS PHARMACEUTICALS MARKET SIZE, BY TOPICAL, 2018-2030 (USD MILLION)
TABLE 271. ISRAEL CANNABIS PHARMACEUTICALS MARKET SIZE, BY COMPOUND TYPE, 2018-2030 (USD MILLION)
TABLE 272. ISRAEL CANNABIS PHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 273. ISRAEL CANNABIS PHARMACEUTICALS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 274. ISRAEL CANNABIS PHARMACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 275. ISRAEL CANNABIS PHARMACEUTICALS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 276. NORWAY CANNABIS PHARMACEUTICALS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 277. NORWAY CANNABIS PHARMACEUTICALS MARKET SIZE, BY CAPSULE, 2018-2030 (USD MILLION)
TABLE 278. NORWAY CANNABIS PHARMACEUTICALS MARKET SIZE, BY OIL, 2018-2030 (USD MILLION)
TABLE 279. NORWAY CANNABIS PHARMACEUTICALS MARKET SIZE, BY TOPICAL, 2018-2030 (USD MILLION)
TABLE 280. NORWAY CANNABIS PHARMACEUTICALS MARKET SIZE, BY COMPOUND TYPE, 2018-2030 (USD MILLION)
TABLE 281. NORWAY CANNABIS PHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 282. NORWAY CANNABIS PHARMACEUTICALS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 283. NORWAY CANNABIS PHARMACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 284. NORWAY CANNABIS PHARMACEUTICALS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 285. POLAND CANNABIS PHARMACEUTICALS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 286. POLAND CANNABIS PHARMACEUTICALS MARKET SIZE, BY CAPSULE, 2018-2030 (USD MILLION)
TABLE 287. POLAND CANNABIS PHARMACEUTICALS MARKET SIZE, BY OIL, 2018-2030 (USD MILLION)
TABLE 288. POLAND CANNABIS PHARMACEUTICALS MARKET SIZE, BY TOPICAL, 2018-2030 (USD MILLION)
TABLE 289. POLAND CANNABIS PHARMACEUTICALS MARKET SIZE, BY COMPOUND TYPE, 2018-2030 (USD MILLION)
TABLE 290. POLAND CANNABIS PHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 291. POLAND CANNABIS PHARMACEUTICALS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 292. POLAND CANNABIS PHARMACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 293. POLAND CANNABIS PHARMACEUTICALS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 294. SWITZERLAND CANNABIS PHARMACEUTICALS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 295. SWITZERLAND CANNABIS PHARMACEUTICALS MARKET SIZE, BY CAPSULE, 2018-2030 (USD MILLION)
TABLE 296. SWITZERLAND CANNABIS PHARMACEUTICALS MARKET SIZE, BY OIL, 2018-2030 (USD MILLION)
TABLE 297. SWITZERLAND CANNABIS PHARMACEUTICALS MARKET SIZE, BY TOPICAL, 2018-2030 (USD MILLION)
TABLE 298. SWITZERLAND CANNABIS PHARMACEUTICALS MARKET SIZE, BY COMPOUND TYPE, 2018-2030 (USD MILLION)
TABLE 299. SWITZERLAND CANNABIS PHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 300. SWITZERLAND CANNABIS PHARMACEUTICALS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 301. SWITZERLAND CANNABIS PHARMACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 302. SWITZERLAND CANNABIS PHARMACEUTICALS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 303. ASIA-PACIFIC CANNABIS PHARMACEUTICALS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 304. ASIA-PACIFIC CANNABIS PHARMACEUTICALS MARKET SIZE, BY CAPSULE, 2018-2030 (USD MILLION)
TABLE 305. ASIA-PACIFIC CANNABIS PHARMACEUTICALS MARKET SIZE, BY OIL, 2018-2030 (USD MILLION)
TABLE 306. ASIA-PACIFIC CANNABIS PHARMACEUTICALS MARKET SIZE, BY TOPICAL, 2018-2030 (USD MILLION)
TABLE 307. ASIA-PACIFIC CANNABIS PHARMACEUTICALS MARKET SIZE, BY COMPOUND TYPE, 2018-2030 (USD MILLION)
TABLE 308. ASIA-PACIFIC CANNABIS PHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 309. ASIA-PACIFIC CANNABIS PHARMACEUTICALS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 310. ASIA-PACIFIC CANNABIS PHARMACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 311. ASIA-PACIFIC CANNABIS PHARMACEUTICALS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 312. ASIA-PACIFIC CANNABIS PHARMACEUTICALS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 313. CHINA CANNABIS PHARMACEUTICALS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 314. CHINA CANNABIS PHARMACEUTICALS MARKET SIZE, BY CAPSULE, 2018-2030 (USD MILLION)
TABLE 315. CHINA CANNABIS PHARMACEUTICALS MARKET SIZE, BY OIL, 2018-2030 (USD MILLION)
TABLE 316. CHINA CANNABIS PHARMACEUTICALS MARKET SIZE, BY TOPICAL, 2018-2030 (USD MILLION)
TABLE 317. CHINA CANNABIS PHARMACEUTICALS MARKET SIZE, BY COMPOUND TYPE, 2018-2030 (USD MILLION)
TABLE 318. CHINA CANNABIS PHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 319. CHINA CANNABIS PHARMACEUTICALS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 320. CHINA CANNABIS PHARMACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 321. CHINA CANNABIS PHARMACEUTICALS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 322. INDIA CANNABIS PHARMACEUTICALS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 323. INDIA CANNABIS PHARMACEUTICALS MARKET SIZE, BY CAPSULE, 2018-2030 (USD MILLION)
TABLE 324. INDIA CANNABIS PHARMACEUTICALS MARKET SIZE, BY OIL, 2018-2030 (USD MILLION)
TABLE 325. INDIA CANNABIS PHARMACEUTICALS MARKET SIZE, BY TOPICAL, 2018-2030 (USD MILLION)
TABLE 326. INDIA CANNABIS PHARMACEUTICALS MARKET SIZE, BY COMPOUND TYPE, 2018-2030 (USD MILLION)
TABLE 327. INDIA CANNABIS PHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 328. INDIA CANNABIS PHARMACEUTICALS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 329. INDIA CANNABIS PHARMACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 330. INDIA CANNABIS PHARMACEUTICALS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 331. JAPAN CANNABIS PHARMACEUTICALS MAR

Companies Mentioned

The companies profiled in this Cannabis Pharmaceuticals market report include:
  • Jazz Pharmaceuticals plc
  • Canopy Growth Corporation
  • Tilray Brands, Inc.
  • Aurora Cannabis Inc.
  • Cronos Group Inc.
  • Curaleaf Holdings, Inc.
  • Trulieve Cannabis Corp.
  • Organigram Holdings Inc.
  • Hexo Corp.
  • MediPharm Labs Corp.

Methodology

Loading
LOADING...

Table Information

Report AttributeDetails
No. of Pages182
PublishedMay 2025
Forecast Period2025 - 2030
Estimated Market Value ( USD ) in 2025 $ 2.04 Billion
Forecasted Market Value ( USD ) by 2030 $ 4.83 Billion
Compound Annual Growth Rate18.8%
Regions CoveredGlobal
No. of Companies Mentioned11

Related Topics

Related Reports

Cannabis Market by Product Type, Application, Distribution Channel, Cultivation Method, Extraction Method, Active Ingredient - Global Forecast to 2030 - Product Image

Cannabis Market by Product Type, Application, Distribution Channel, Cultivation Method, Extraction Method, Active Ingredient - Global Forecast to 2030

  • Report
  • 184 Pages
  • Global
From
Cannabis Extraction Market by Extraction Method, Product Type, End Use, Equipment Type, Compound Type, Form - Global Forecast to 2030 - Product Image

Cannabis Extraction Market by Extraction Method, Product Type, End Use, Equipment Type, Compound Type, Form - Global Forecast to 2030

  • Report
  • 199 Pages
  • Global
From
Medical Cannabis Market Report 2025-2033 - Product Image

Medical Cannabis Market Report 2025-2033

  • Report
  • 125 Pages
  • Global
From
Cannabis Pharmaceuticals - Global Strategic Business Report - Product Image

Cannabis Pharmaceuticals - Global Strategic Business Report

  • Report
  • 116 Pages
  • Global
From
Cannabis Pharmaceuticals Market by Product, by Distribution Channel, and by Region - Product Image

Cannabis Pharmaceuticals Market by Product, by Distribution Channel, and by Region

  • Report
  • 200 Pages
  • Global
From

About the Cannabis Pharmaceuticals Market

The Cannabis Pharmaceuticals market within the context of Analgesics is a rapidly growing sector of the pharmaceutical industry. Cannabis-based pharmaceuticals are used to treat a variety of conditions, including chronic pain, inflammation, and neurological disorders. These drugs are often used in combination with traditional analgesics to provide a more comprehensive approach to pain management. Cannabis-based pharmaceuticals are also being studied for their potential to reduce opioid dependence and addiction. Cannabis-based pharmaceuticals are available in a variety of forms, including oral capsules, topical creams, and sublingual sprays. These products are often formulated with other active ingredients, such as cannabinoids, terpenes, and flavonoids, to provide additional therapeutic benefits. Several companies are currently operating in the Cannabis Pharmaceuticals market, including GW Pharmaceuticals, Tilray, and Zynerba Pharmaceuticals. These companies are focused on developing and commercializing cannabis-based pharmaceuticals for the treatment of various conditions. Show Less Read more

Copyright © 2002-2025 Research and Markets. All Rights Reserved.